Quantcast

Latest Channelopathy Stories

2009-07-28 10:30:00

Seven applicants receive a total of over $1.7 million BERWYN, Pa., July 28 /PRNewswire-USNewswire/ -- The NephCure Foundation (NCF) has awarded more than $1.7 million to researchers in its 2009 Scientific Research Grant Program. The announcement was made by Henry Brehm, NephCure Foundation's Executive Director and Dr. Lawrence Holzman, Chair of the NCF Scientific Advisory Board. The Scientific Grant Program supports basic, transitional and clinical research initiatives to understand the...

2009-07-21 12:19:19

Using a common cold virus to deliver a corrected gene to cystic fibrosis cells restores normal function to lung tissue, researchers in North Carolina said. The treatment is the most efficient gene therapy for cystic fibrosis to be found in the last 20 years, researchers at the University of North Carolina said Tuesday in a release. The next step is to ensure the safety of the delivery system so it can be administered to cystic fibrosis patients, who suffer from thicker-than-normal mucus that...

2009-07-16 11:10:19

Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests.The treatments not only help breathing in the short term - they may also make lung infections develop to be less harmful in the long run, research from the University of Edinburgh shows.Scientists studied how bacteria which infect the lungs of cystic fibrosis patients gather nutrients from their surroundings. The work builds on the knowledge that most bacteria...

2009-05-28 07:32:00

LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). RP is a slowly developing condition that causes the progressive degeneration of rod & cone photoreceptor cells in the retina that over time diminishes night and peripheral vision and eventually leads to blindness. RP is an orphan-designated indication for which...

2009-05-21 06:45:00

WASHINGTON, May 21 /PRNewswire-USNewswire/ -- Before your kids are out the schoolroom door and off to the pool or baseball field this summer, take a few preventive steps to help protect their hearts. Prevention may be as simple as making sure children eat nutritious meals, exercise, stay away from cigarettes and have check-ups. Be aware that for some children who have an inherited heart disorder known as Long QT Syndrome, research shows that typical summer activities can trigger sudden...

2009-05-20 12:28:06

U.S. pharmaceutical researchers say a new sodium channel blocker is showing promise as a potential treatment for cystic fibrosis. Scientists who developed the drug at Parion Sciences Inc. in Durham, N.C., said cystic fibrosis patients could benefit from the medication that increases airway hydration and prevents the buildup of mucous. Our results suggest that we have identified a new agent that acts directly on a specific pathway, which is involved in the development of cystic fibrosis,...

2009-05-18 08:52:16

Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to researchers at Parion Sciences in Durham, N.C.The research will be presented on Sunday, May 17, during the American Thoracic Society's 105th International Conference in San Diego."Our results suggest that we have identified a new agent that acts directly on a specific pathway, which is involved in the development of...

2009-05-11 07:39:13

The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease "“ the features or disorders associated with it "“ vary in type and severity among those who are affected. Scientists, physicians and patients all ask why. In this week's journal Nature Genetics, an international consortium of researchers, including some from Baylor College of Medicine, provide not only an explanation for the variations of vision loss in...

2009-04-29 19:55:00

WASHINGTON, April 29 /PRNewswire/ -- Vision loss is a high priority area for VA Research. Among VA's research projects in the exciting domain of vision restoration for Veterans are the development of an artificial retina to restore vision to those affected by macular degeneration and retinitis pigmentosa; the design and improvement of assistive devices for those with visual impairments; and the development of more accurate and efficient methods of vision testing. To view the Multimedia News...

2009-04-20 12:08:34

Omega three fatty acids protect brain cells by preventing the misfolding of a protein from a gene mutation in Parkinson's disease, U.S. researchers said. Dr. Nicolas Bazan of Louisiana State University and colleagues developed a cell model with a mutation of the Ataxin-1 gene. The defective Ataxin-1 gene induced the misfolding of the protein produced by the gene. The misshapened proteins cannot be properly processed by the cell machinery, resulting in tangled clumps of toxic protein that...


Latest Channelopathy Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related